Skip to main content
. 2024 Jun 4;300(7):107451. doi: 10.1016/j.jbc.2024.107451

Table 2.

Potency of human soluble CR1 LHR-A domain variants in C3b and C4b cofactor activity assays

Human CR1 truncation
Cofactor activity (pM ± SD)
Domain C4b C3b
LHR-ABC/CSL040 860 ± 290 78.9 ± 20.2
LHR-A 20,460 ± 3280∗∗∗ No activity
LHR-AA 16,650 ± 2700∗∗∗ No activity
LHR-AAA 11,800 ± 4700∗ Not tested
LHR-AAAA 14,690 ± 4220∗∗ Not tested

The IC50 values listed are the mean ± SD co-factor activity (in pM) of three independent experiments, shown graphically in Figure 3. Statistically significant differences for LHR-A domain variant IC50 values compared to LHR-ABC/CSL040 were calculated by an unpaired t test; ∗ p < 0.05; ∗∗ p < 0.005; and ∗∗∗ p < 0.0005.

CR1, complement receptor 1; LHR, long homologous repeat.